Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Diacetato(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxoleruthenium(II) Ru(OAc)2[(R)-dm-segphos], also known as (R)-Rutheniumdiacetate-(DM-SEGPHOS), is a coordination compound that plays a significant role in the field of asymmetric catalysis. It is characterized by its unique structure, which includes a ruthenium(II) center coordinated to a diacetato ligand and a chiral bis(3,5-xylyl)phosphino ligand. Diacetato(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxoleruthenium(II) Ru(OAc)2[(R)-dm-segphos] is known for its ability to facilitate the direct asymmetric reductive amination of ketones and aldehydes, enabling the synthesis of enantioenriched amines.

944450-49-1

Post Buying Request

944450-49-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos]

    Cas No: 944450-49-1

  • USD $ 10.0-10.0 / Milligram

  • 1 Milligram

  • 100000000 Kilogram/Month

  • weifang yangxu group co.,ltd
  • Contact Supplier
  • Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}rutheniuM(II) Ru(OAc)2[(R)-dM-segphos ]

    Cas No: 944450-49-1

  • No Data

  • No Data

  • No Data

  • Antimex Chemical Limied
  • Contact Supplier
  • Diacetato{(R)-(+)-5,5-bis[di(3,5-xylyl)phosphino]-4,4-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos]

    Cas No: 944450-49-1

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier
  • Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos?]

    Cas No: 944450-49-1

  • No Data

  • No Data

  • No Data

  • Strem Chemicals, Inc.
  • Contact Supplier

944450-49-1 Usage

Uses

Used in Pharmaceutical Industry:
Diacetato(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxoleruthenium(II) Ru(OAc)2[(R)-dm-segphos] is used as a catalyst for the direct asymmetric reductive amination of ketones and aldehydes. This process is crucial for the synthesis of enantioenriched amines, which are key building blocks in the production of various pharmaceuticals and agrochemicals. The use of Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos] allows for the efficient and selective synthesis of these amines, contributing to the development of new and improved drugs.
Used in Chemical Synthesis:
In the field of chemical synthesis, Diacetato(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxoleruthenium(II) Ru(OAc)2[(R)-dm-segphos] is employed as a catalyst for the direct asymmetric reductive amination of ketones and aldehydes. This reaction is an important method for the preparation of chiral amines, which are widely used as intermediates in the synthesis of various organic compounds, including natural products, pharmaceuticals, and agrochemicals. The use of Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos] as a catalyst enables the selective formation of the desired enantiomer, improving the overall efficiency and selectivity of the synthesis process.
Used in Research and Development:
Diacetato(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxoleruthenium(II) Ru(OAc)2[(R)-dm-segphos] is also used in research and development settings to explore new methods and strategies for asymmetric catalysis. The unique structure and properties of Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos] make it an attractive candidate for the development of new catalytic systems and the investigation of reaction mechanisms. By studying the behavior of Diacetato{(R)-(+)-5,5'-bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole}ruthenium(II) Ru(OAc)2[(R)-dm-segphos] in various reactions, researchers can gain valuable insights into the factors that govern enantioselectivity and develop new strategies for the synthesis of chiral compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 944450-49-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,4,5 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 944450-49:
(8*9)+(7*4)+(6*4)+(5*4)+(4*5)+(3*0)+(2*4)+(1*9)=181
181 % 10 = 1
So 944450-49-1 is a valid CAS Registry Number.

944450-49-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Ru(OAc)2((R)-dm-segphos)

1.2 Other means of identification

Product number -
Other names DIACETATO{(R)-(+)-5,5'-BIS[DI(3,5-XYLYL)PHOSPHINO]-4,4'-BI-1,3-BENZODIOXOLE}RUTHENIUM(II)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:944450-49-1 SDS

944450-49-1Downstream Products

944450-49-1Relevant articles and documents

Dynamic Kinetic Asymmetric Reductive Amination: Synthesis of Chiral Primary β-Amino Lactams

Lou, Yazhou,Hu, Yutao,Lu, Jiaxiang,Guan, Fanfu,Gong, Gelin,Yin, Qin,Zhang, Xumu

supporting information, p. 14193 - 14197 (2018/10/15)

A highly efficient ruthenium-catalyzed asymmetric reductive amination (ARA) of racemic β-keto lactams with molecular hydrogen and ammonium salts is disclosed for the synthesis of enantiomerically pure primary amino lactams through dynamic kinetic resolution (DKR). By this approach, a range of syn primary β-amino lactams were obtained in high yields with high chemo-, enantio-, and diastereoselectivity (up to 98 % yield, 99 % ee, >20:1 d.r., syn products). The utility of the products has been demonstrated by rapid access to a key synthetic intermediate towards biologically active drug molecules. Meanwhile, mechanistic studies and control experiments indicate that the reaction may proceed through the hydrogenation of an iminium intermediate.

METHOD FOR PRODUCING A RUTHENIUM COMPLEX

-

Page/Page column 7, (2010/04/23)

Provided is a method for producing a ruthenium complex comprises the step of reacting a ruthenium compound represented by general formula (1): [in-line-formulae][RuX(L)(PP)]X ??(1),[/in-line-formulae] wherein Ru represents a ruthenium atom; X represents a halogen atom; L represents an arene; and PP represents an optically active bisphosphine, with a carboxylate salt represented by general formula (2): [in-line-formulae]R1CO2M ??(2),[/in-line-formulae] wherein M represents a monovalent cation; and R1 represents a group selected from the group consisting of alkyl groups, haloalkyl groups, phenyl groups optionally having a substituent(s), 1-aminoalkyl groups and 1-amino-1-phenylalkyl groups, to produce a ruthenium complex represented by general formula (3): [in-line-formulae]Ru(OCOR1)2(PP) ??(3),[/in-line-formulae] wherein R1 represents the group selected from the group consisting of alkyl groups, haloalkyl groups, phenyl groups optionally having a substituent(s), 1-aminoalkyl groups and 1-amino-1-phenylalkyl groups; and PP represents the optically active bisphosphine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 944450-49-1